Bioline Rx reported $39.8M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Arca Biopharma USD 504.48M 15.86M Mar/2026
Bio Path USD 677K 13K Mar/2026
Bioline Rx USD 39.8M 3.47M Sep/2025
Capricor Therapeutics USD 326.28M 29.66M Mar/2026